Investigating Neurocognitive Disorders Epidemiology
Recruiting now
Conditions studied: Dementia, Cognitive Decline, Alzheimer Disease
In brief
This is a prospective cohort study with the main purpose of predicting progression neurocognitive disorders in Thai population. The main predictor variables to be evaluated are plasma phosphorylated tau (p-tau) level and cognitive test scores, which will be combined using statistical/computational modeling. Additionally, it seeks to evaluate biomarkers for diagnosing disease pathologies, understand their correlation with clinical outcomes, and explore the socioeconomic impact of neurocognitive disorders. The study invites both participants for biospecimen collection, structured interviews, and cognitive examinations and schedules follow-up visits annually or biennially.
Key facts
- Study ID
- NCT06375213
- Run by
- King Chulalongkorn Memorial Hospital
- People needed
- 990
- Starts
- 2023-08-24
- Expected to finish
- 2035-08-24
- Last updated by the study team
- 2024-04-22
Who can join
Age: 35 and older. Sex: any. Healthy volunteers: accepted.
You may qualify if…
- Demonstrate normal cognitive function within the expected range on objective cognitive tests.
- Proficient in speaking and understanding Thai without the need for a translator to participate.
You may not qualify if…
- Significant neurological or uncontrolled psychiatric illness.
- Significant unstable systemic condition or end-stage organ failure that affects study participation.
- Mild Cognitive Impairment
- INCLUSION CRITERIA
- Display impaired/abnormal performance on objective cognitive tests.
- Does not meet criteria for dementia per NIA-AA (or major neurocognitive disorder per DSM-5).
- Proficient in speaking and understanding Thai without the need for a translator to participate.
- EXCLUSION CRITERIA
- Significant neurological or uncontrolled psychiatric illness.
- Significant unstable systemic condition or end-stage organ failure that affects study participation.
- Late Onset Dementia
- INCLUSION CRITERIA
- Display impaired/abnormal performance on objective cognitive tests.
- Meets criteria for dementia per NIA-AA (or major neurocognitive disorder per DSM-5), including dementia due to Alzheimer's disease or other causes.
- Begins to experience symptoms, identified by the physician as a part of dementia continuum, occurring after the age of 65.
- Proficient in speaking and understanding Thai without the need for a translator to participate.
- EXCLUSION CRITERIA
- Significant neurological or uncontrolled psychiatric illness.
- Significant unstable systemic condition or end-stage organ failure that affects study participation.
- Early Onset Dementia
- INCLUSION CRITERIA
- Display impaired/abnormal performance on objective cognitive tests.
- Meets criteria for dementia per NIA-AA (or major neurocognitive disorder per DSM-5), including dementia due to Alzheimer's disease or other causes.
- Begins to experience symptoms, identified by the physician as a part of dementia continuum, occurring before the age of 65.
- Proficient in speaking and understanding Thai without the need for a translator to participate.
Where it is running
- King Chulalongkorn Memorial Hospital — Pathum Wan, Bangkok, Thailand (enrolling)
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.